During the past decade, Southwest VA Regional Cancer Center conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 62 clinical trials were completed, i.e. on average, 134.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 30 clinical trials were completed. i.e. 187.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest VA Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 62 trials, followed by "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NSABP Foundation Inc" with 9 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest VA Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 7 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Southwest VA Regional Cancer Center" are "Lung Cancer" (8 trials), "Breast Cancer" (6 trials), "Clear Cell Renal Cell Carcinoma" (5 trials), "Colorectal Cancer" (5 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Southwest VA Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Southwest VA Regional Cancer Center" are "Drug" (107 trials), "Other" (72 trials), "Biological" (45 trials), "Procedure" (24 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (30 trials), "Paclitaxel" (19 trials), "Bevacizumab" (15 trials) and "Computed Tomography" (15 trials). Other intervention names were less common.

The vast majority of trials in "Southwest VA Regional Cancer Center" are 96 trials for "All" genders, 22 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Southwest VA Regional Cancer Center". undefined are not yet recruiting, 15 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Southwest VA Regional Cancer Center, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest VA Regional Cancer Center, 3 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".